Robinhood Ventures Fund II began trading on the New York Stock Exchange today under the ticker RVII, listing at $25.00…
Adialante is working to make MRI-based cancer screening accessible beyond major hospital centers.
CellType runs agentic drug discovery on simulated human biology, letting AI agents test hypotheses before wet-lab work begins.
Robinhood Ventures Fund II backs healthcare AI startups spanning simulated drug discovery, accessible imaging, and clinical operations.
The Miami chronic care platform lands a $25M growth facility to scale its AI-powered remote monitoring.
TidalSense raised $19 million for an AI-powered breath test that detects COPD in 75 seconds without traditional spirometry.
Doctronic's acquisition of text-based pediatric provider Summer Health opens a new front in AI-driven primary care.
Teladoc Health launches Teladoc One with 100% fee-at-risk model, using AI and unified data to coordinate care across virtual and…